50 ML albumin human-kjda 250 MG/ML Injection [Albuminex]
RxNorm concept 2054170, branded drug (sbd). Prescribable name: ALBUMINEX 25 % in 50 ML Injection.
- RxCUI
- 2054170
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2054170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Albuminex 25 % per 50 ML Injection; Albuminex 250 MG/ML per 50 ML Injection
Related concepts
- albumin human-kjda 250 MG/ML (SCDC, consists of)
- albumin human-kjda 250 MG/ML [Albuminex] (SBDC, consists of)
- {1 (4 ML docetaxel 20 MG/ML Injection [Beizray]) / 1 (50 ML albumin human-kjda 250 MG/ML Injection [Albuminex]) } Pack [Beizray 80 MG Kit] (BPCK, contained in)
- {2 (4 ML docetaxel 20 MG/ML Injection [Beizray]) / 1 (50 ML albumin human-kjda 250 MG/ML Injection [Albuminex]) } Pack [Beizray 160 MG Kit] (BPCK, contained in)
- Injection (DF, has dose form)
- Albuminex (BN, has ingredient)
- 50 ML albumin human-kjda 250 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2054170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2054170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2054170. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.